Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOKYO.L Regulatory News (OKYO)

  • There is currently no data for OKYO

ADS Program collapse

19 May 2023 08:00

RNS Number : 9540Z
OKYO Pharma Limited
19 May 2023
 

 

OKYO PHARMA LIMITED

ADS Program collapse - Commencement of trading of new ordinary shares on The Nasdaq Capital Market

LONDON and NEW YORK, May 19, 2023 -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO) hereby announces that following the implementation of the share capital consolidation and collapse of its ADS program, it is expected that new OKYO ordinary shares will be listed on The Nasdaq Capital Market with effect from the opening of business in New York on Monday May, 22, 2023.

OKYO has been listed on The Nasdaq Capital Market via an ADS since May 17 2022. OYKO announced its intention to delist from the London Stock Exchange plc on April 2, 2023 and on May 3, 2023 shareholders passed the necessary resolutions to consolidate its existing ordinary shares by a 65 into 1 reverse split (thereby matching the current ADS ratio of 65 ordinary shares comprised in each ADS). Each new OKYO ordinary share will accordingly represent 65 of the old ordinary shares and be equal to one ADS.

The CUSIP for the new OKYO ordinary shares is G6724L116 and the ISIN is GG00BMFG5F62.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAKSPFSNDEFA
Date   Source Headline
14th Jul 20104:37 pmPRNHoldings in Company
9th Jul 201011:44 amPRNDisposal
7th May 201010:20 amPRNDealings by Directors
27th Apr 20107:00 amPRNDealings by Directors
20th Apr 20104:05 pmPRNIssue of Equity/Dealings by Directors
16th Apr 201012:21 pmPRNResult of Meeting and Dividend Declaration
13th Apr 20107:00 amPRNExercise of Options and Dealings by Directors
1st Apr 20107:00 amPRNNotice of Meeting of Shareholders and Disposal
26th Mar 201010:45 amPRNDisposal and Change of Name of Nominated Adviser
19th Feb 201010:13 amPRNStatement re: Announcement by Extract Resources
25th Jan 20101:30 pmPRNRe: Kalahari Minerals & NWT Uranium Announcement
24th Dec 20097:00 amPRNUnaudited interim financial statements
23rd Jul 20094:04 pmPRNResult of Annual General Meeting
14th Jul 200910:43 amPRNDirectorate Change
8th Jul 20097:30 amPRNNotice of Annual General Meeting
8th Jul 20097:00 amPRNFinal Results
19th Jun 20097:40 amPRNHolding(s) in Company
17th Apr 200910:00 amRNSHolding(s) in Company
14th Apr 20092:50 pmPRNResult of Meeting of Shareholders
1st Apr 20092:19 pmPRNNotice of Meeting of Shareholders
24th Feb 20097:18 amPRNIncrease of significant interest in Kalahari Minerals
23rd Feb 20094:47 pmRNSEmerging Metals Increases Stake
19th Feb 20097:00 amRNSNotice of Major Shareholdings by Emerging Metals
19th Feb 20097:00 amPRNIncrease of significant interest in Kalahari Minerals
23rd Dec 20087:00 amPRNInterim Financial Statements
18th Dec 20087:00 amRNSNotice of Major Shareholdings by Emerging Metals
10th Dec 20087:00 amPRNAcquisition of significant interest in Kalahari Minerals
17th Nov 20089:05 amPRNNotification of significant interest
1st Jul 20087:00 amPRNFirst day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.